PFMU
ALXN

Privium Fund Management (UK)’s Alexion Pharmaceuticals ALXN Stock Holding History

Privium Fund Management (UK)’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-17,953
Closed -$2.78M – 96
2021
Q2 		$2.78M Sell
17,953
-2,047
-10% -$351K 1.94% 13
2021
Q1 		$3.06M Buy
20,000
+8,000
+67% +$1.24M 2.13% 13
2020
Q4 		$1.47M Buy
+12,000
New +$1.54M 1.13% 27

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Privium Fund Management (UK)'s ALXN Position: Q3 2021 in Review

Privium Fund Management (UK) sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 17,953 shares — an estimated $2.78M sold.

Privium Fund Management (UK) first reported a position in ALXN in Q4 2020 and held it in 3 quarters. The position peaked at $3.06M in Q1 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Privium Fund Management (UK) reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Privium Fund Management (UK) sold 17,953 Alexion Pharmaceuticals shares in Q3 2021, an estimated $2.78M.
  • Privium Fund Management (UK) first reported a position in Alexion Pharmaceuticals in Q4 2020 and held it in 3 quarters.
  • Privium Fund Management (UK)'s Alexion Pharmaceuticals position peaked at $3.06M in Q1 2021.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Privium Fund Management (UK)'s 13F filing for Q3 2021, filed 5 Nov 2021.